Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo fkansteiner Tue, 01/24/2023 – 16:13 More: Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo Source: fierce
read moreNovartis, in SCOTUS filing, argues it was ‘wrongly deprived’ of Gilenya patent after judge’s retirement zbecker Tue, 01/24/2023 – 11:21 More: Novartis, in SCOTUS filing, argues it was 'wrongly deprived' of Gilenya patent after judge's retirement Source: fierce
read moreJ&J’s Duato keeps $60B sales target in sight even as Imbruvica slides and Stelara nears patent cliff fkansteiner Tue, 01/24/2023 – 11:19 More: J&J's Duato keeps B sales target in sight even as Imbruvica slides and Stelara nears patent cliff
read moreHow a buyer’s sudden withdrawal gave Ipsen a chance to fight for Albireo aliu Tue, 01/24/2023 – 10:29 More: How a buyer's sudden withdrawal gave Ipsen a chance to fight for Albireo Source: fierce
read moreGeorgia Tech spinout bags cash for nucleic acid delivery R&D ntaylor Tue, 01/24/2023 – 10:10 More: Georgia Tech spinout bags cash for nucleic acid delivery R&D Source: fierce
read moreAmber-UI presents a significant opportunity to treat urge and mixed urinary incontinence More: First-in-human implants for Amber Therapeutics’ bioelectrical therapy Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals